Seer Receives Competing Acquisition Proposals at $2.45–$2.55 per Share
Event summary
- Seer received a revised unsolicited acquisition proposal from Radoff-JEC Group for $2.55 per share plus contingent value rights on July 28, 2026.
- On July 29, 2026, Seer’s CEO Omid Farokhzad submitted a competing offer at $2.45 per share plus two separate contingent value rights.
- Seer’s Special Committee will review both proposals and determine the best course of action for shareholders.
The big picture
Seer’s competing acquisition bids reflect broader consolidation trends in the proteomics sector, where scale and technological integration are becoming critical. The involvement of both an external group and the company’s CEO underscores governance complexities in biotech M&A, particularly when founder-led firms face strategic inflection points.
What we're watching
- Bid Competition
- Whether the Radoff-JEC Group’s higher offer will prompt further revisions or counterproposals from Farokhzad.
- Shareholder Response
- How investors react to the competing bids, particularly given the contingent value rights attached to both offers.
- Special Committee Decision
- The timeline and criteria the Special Committee will use to evaluate the proposals and recommend a path forward.
Related topics